Stockreport

Regenxbio outlines 2026 Duchenne, wet AMD, and diabetic retinopathy milestones while targeting pivotal data releases [Seeking Alpha]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF Curran Simpson, President and CEO, stated, "2026 is set to be a pivotal year for REGENXBIO with great focus on advancing our late-stage pipeline in 2025," emphasizing n [Read more]